Tom Rodgers

Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.

Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more. With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers. In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.

Packable offers a suite of end-to-end commerce services that retail sellers can choose based on their specific needs and maturity levels. These services include marketplace enablement, E-commerce fulfillment and logistics, and other value-added services. Our mission is to superpower the most ambitious businesses in the world by driving sales, removing burdens, providing clarity on the bigger picture, and simplifying challenges: enabling brands to connect to more markets, consumers and sales.

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com. Community Guidelines: https://bit.ly/3xigb24

Kyruus delivers leading enterprise provider search and scheduling solutions that help health systems match patients with the right providers across points of access. Powered by a robust provider data management platform, the ProviderMatch suite of applications - for consumers, access centers, & care settings - enables health systems to enhance the patient experience and better align patient demand with network capacity. To find out why a Better Match Means Better Care, visit http://www.kyruus.com.

Evariant, a Healthgrades company, enables providers to optimize growth through smarter consumer acquisition, patient retention, and network utilization strategies through healthcare’s only Patients for Life Platform. Our customers achieve indisputable value through high-value service line growth, improving provider network utilization and planning, and extending patient lifetime value. Our solutions deliver actionable intelligence that enable healthcare providers to find, guide, and keep patients for life. For more information, visit www.evariant.com

During the moments that matter in healthcare, your people need to be seen, heard and understood for who they are. Accolade is a Personalized Healthcare company that puts humanity back in healthcare for your employees by building relationships that connect them and their families to the right care at the right time. We deliver care that is personalized, guided by intelligent technology and data insights, and value based, to deliver improved clinical outcomes and lower costs. We’ve been recognized as one of the nation’s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500, and a top workplace by multiple publications. For more information, visit www.accolade.com.

At Gynesonics our mission is to design and develop new and advanced technologies for improving women’s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. If your post, comment or message references an adverse event with the Sonata Treatment, we may contact you for more information. To monitor the safety of our products, we encourage you to report suspected adverse effects by calling Gynesonics at 844-723-5382 Monday – Friday 9 AM – 5 PM EST. Alternatively, you can report any serious side effects directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. We are committed to responding to your messages promptly. Our regular business hours are [Monday – Friday 9 AM – 5 PM EST. If a message is sent or a comment is made outside of regular business hours, or on weekends or company holidays, we will respond when business resumes. Please call 911 in the event of an emergency.

For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio products are transforming the practice of pathology in hospitals, reference labs and pharmaceutical and research institutions around the world. From the moment glass slides are elevated to eSlides, Aperio ePathology Solutions equip pathologists with the power to evaluate, engage and excel like never before. The NETWORK enables remote, simultaneous, real-time viewing and easy distribution for consults and collaboration. PRECISION tools empower pathologists with advanced analytic capabilities. An interoperable, scalable and secure web-based software platform facilitates integration with existing systems. With Aperio ePathology Solutions, organizations can optimize their pathology operations for transparency, consistency and efficiency to support patient care, personalized medicine and research. For clearance updates, specific product indications, and more information please visit www.aperio.com. Aperio was founded in 1999 and is headquartered in Vista, CA, approximately 35 miles north of San Diego.

Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.

Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more. With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers. In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.

Packable offers a suite of end-to-end commerce services that retail sellers can choose based on their specific needs and maturity levels. These services include marketplace enablement, E-commerce fulfillment and logistics, and other value-added services. Our mission is to superpower the most ambitious businesses in the world by driving sales, removing burdens, providing clarity on the bigger picture, and simplifying challenges: enabling brands to connect to more markets, consumers and sales.

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com. Community Guidelines: https://bit.ly/3xigb24

Kyruus delivers leading enterprise provider search and scheduling solutions that help health systems match patients with the right providers across points of access. Powered by a robust provider data management platform, the ProviderMatch suite of applications - for consumers, access centers, & care settings - enables health systems to enhance the patient experience and better align patient demand with network capacity. To find out why a Better Match Means Better Care, visit http://www.kyruus.com.